5,7-dihydroxytryptamine has been researched along with senktide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hill, DR; Stoessl, AJ | 1 |
| Lorens, SA; Mitsushio, H; Paris, JM | 1 |
2 other study(ies) available for 5,7-dihydroxytryptamine and senktide
| Article | Year |
|---|---|
Autoradiographic visualization of NK-3 tachykinin binding sites in the rat brain, utilizing [3H]senktide.
Topics: 5,7-Dihydroxytryptamine; Animals; Autoradiography; Brain; Kinetics; Male; Organ Specificity; Paroxetine; Peptide Fragments; Piperidines; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Reference Values; Serotonin Antagonists; Substance P; Tachykinins; Tritium | 1990 |
Intra-raphe neurokinin-induced hyperactivity: effects of 5,7-dihydroxytryptamine lesions.
Topics: 5,7-Dihydroxytryptamine; Action Potentials; Animals; Catecholamines; Dihydroxytryptamines; Male; Medial Forebrain Bundle; Motor Activity; Neural Pathways; Neurokinin A; Peptide Fragments; Pyrrolidonecarboxylic Acid; Raphe Nuclei; Rats; Rats, Inbred Strains; Serotonin; Substance P | 1989 |